Ian Chau Selected Research

COVID-19

12/2021	Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study.
1/2021	Cytokine release syndrome in a patient with colorectal cancer after vaccination with BNT162b2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ian Chau Research Topics

Disease

108	Neoplasms (Cancer) 05/2024 - 04/2002
43	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 01/2002
29	Adenocarcinoma 11/2023 - 06/2008
26	Stomach Neoplasms (Stomach Cancer) 11/2023 - 11/2007
22	Disease Progression 02/2024 - 08/2003
18	Rectal Neoplasms (Rectal Cancer) 01/2020 - 01/2002
13	Neoplasm Metastasis (Metastasis) 12/2021 - 02/2003
10	Pancreatic Neoplasms (Pancreatic Cancer) 11/2021 - 07/2002
8	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 07/2015
7	Hypertension (High Blood Pressure) 01/2024 - 01/2014
7	Carcinoma (Carcinomatosis) 01/2022 - 09/2010
6	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 04/2023 - 02/2003
6	Lymphoma (Lymphomas) 01/2022 - 09/2002
5	Neutropenia 03/2024 - 07/2002
5	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021 - 04/2007
4	Sepsis (Septicemia) 03/2024 - 01/2020
4	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 09/2002
4	Microsatellite Instability 08/2021 - 01/2020
4	Infections 05/2020 - 07/2002
4	Colonic Neoplasms (Colon Cancer) 01/2020 - 01/2002
4	Melanoma (Melanoma, Malignant) 01/2020 - 08/2015
3	Pain (Aches) 01/2020 - 01/2014
3	Vomiting 01/2019 - 01/2014
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 08/2015
3	Ovarian Neoplasms (Ovarian Cancer) 11/2018 - 01/2011
3	Breast Neoplasms (Breast Cancer) 07/2018 - 01/2011
3	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 05/2018 - 02/2007
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2007 - 09/2002
2	Esophageal Squamous Cell Carcinoma 05/2024 - 01/2022
2	Fever (Fevers) 03/2024 - 05/2020
2	Asthenia 01/2024 - 07/2015
2	B-Cell Lymphoma (Lymphoma, B Cell) 08/2023 - 01/2020
2	Neuroendocrine Carcinoma 06/2023 - 01/2020
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2022 - 01/2017
2	Cardiotoxicity 12/2021 - 10/2018
2	Cytokine Release Syndrome 12/2021 - 01/2021
2	COVID-19 12/2021 - 01/2021

Drug/Important Bio-Agent (IBA)

26	Biomarkers (Surrogate Marker)IBA 02/2024 - 02/2003
22	RamucirumabIBA 01/2021 - 01/2014
17	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 01/2002
15	Fluorouracil (Carac)FDA LinkGeneric 01/2022 - 07/2002
12	PlatinumIBA 08/2022 - 05/2011
12	Irinotecan (Camptosar)FDA LinkGeneric 11/2021 - 01/2002
12	Cetuximab (Erbitux)FDA Link 01/2021 - 07/2004
12	Capecitabine (Xeloda)FDA Link 01/2016 - 01/2004
11	Trastuzumab (Herceptin)FDA Link 01/2023 - 11/2010
11	Gemcitabine FDA Link 12/2018 - 09/2002
9	NivolumabIBA 05/2024 - 07/2016
9	pembrolizumabIBA 11/2023 - 12/2018
9	Monoclonal AntibodiesIBA 08/2022 - 04/2011
9	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 03/2003
8	Immune Checkpoint InhibitorsIBA 04/2024 - 10/2017
8	Leucovorin (Folinic Acid)FDA Link 01/2022 - 05/2003
7	IpilimumabIBA 05/2024 - 07/2016
7	DNA (Deoxyribonucleic Acid)IBA 03/2023 - 11/2013
7	ErbB Receptors (EGF Receptor)IBA 01/2022 - 01/2002
6	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 01/2014
6	Panitumumab (Vectibix)FDA Link 01/2021 - 09/2010
6	VemurafenibIBA 01/2020 - 08/2015
5	B7-H1 AntigenIBA 05/2024 - 10/2018
5	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2024 - 01/2014
5	Docetaxel (Taxotere)FDA Link 06/2023 - 05/2011
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 11/2009
5	Methylprednisolone FDA LinkGeneric 05/2018 - 03/2003
4	Phosphotransferases (Kinase)IBA 02/2024 - 01/2016
4	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2024 - 07/2015
4	Calcibiotic Root Canal SealerIBA 11/2023 - 01/2019
4	ibrutinibIBA 11/2023 - 10/2018
4	Rituximab (Mabthera)FDA Link 08/2023 - 04/2007
4	MicroRNAs (MicroRNA)IBA 01/2023 - 01/2016
4	VaccinesIBA 01/2023 - 10/2016
4	afliberceptIBA 05/2022 - 08/2014
4	folfirinoxIBA 11/2021 - 12/2014
4	AntibodiesIBA 01/2021 - 07/2013
3	Anti-Bacterial Agents (Antibiotics)IBA 03/2024 - 05/2020
3	regorafenibIBA 02/2024 - 01/2018
3	Neutralizing AntibodiesIBA 01/2023 - 12/2021
3	Angiogenesis InhibitorsIBA 05/2022 - 01/2014
3	Bevacizumab (Avastin)FDA Link 12/2019 - 11/2009
3	Sorafenib (BAY 43-9006)FDA Link 01/2018 - 07/2015
3	Matrix Metalloproteinases (MMPs)IBA 01/2017 - 01/2002
2	Meropenem (Merrem)FDA LinkGeneric 03/2024 - 05/2020
2	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 03/2024 - 05/2020
2	COVID-19 VaccinesIBA 01/2023 - 01/2021
2	Formaldehyde (Formol)FDA Link 01/2023 - 09/2017
2	trastuzumab deruxtecanIBA 01/2023 - 01/2021
2	ParaffinIBA 01/2023 - 09/2017
2	human ERBB2 proteinIBA 01/2022 - 07/2018

Therapy/Procedure

79	Therapeutics 03/2024 - 01/2002
72	Drug Therapy (Chemotherapy) 05/2024 - 01/2002
16	Radiotherapy 08/2023 - 01/2002
11	Neoadjuvant Therapy 01/2023 - 06/2008
9	Adjuvant Chemotherapy 03/2023 - 10/2002
9	Chemoradiotherapy 01/2020 - 02/2006
8	Immunotherapy 06/2021 - 12/2015
5	Combination Drug Therapy (Combination Chemotherapy) 08/2021 - 09/2002
4	Aftercare (After-Treatment) 01/2022 - 01/2014
3	Salvage Therapy 01/2020 - 03/2003
2	Critical Care (Surgical Intensive Care) 03/2024 - 05/2020
2	Stem Cell Transplantation 01/2022 - 01/2017